Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCC:PAINDIP trial of collaborative care and duloxetine for major depressive disorder with pain
NL-OMON39433Active, not recruiting
- Sponsor
- GGZ Breburg
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of duloxetine in major depressive disorder (MDD) (3 arms), sponsored by GGZ Breburg. Primary endpoint: Depression severity. Started Dec 2011; status: active, not recruiting.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON39433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39433.